151 related articles for article (PubMed ID: 12072249)
1. Mucosal immunoadjuvant activity of the low toxic recombinant Escherichia coli heat-labile enterotoxin produced by Bacillus brevis for the bacterial subunit or component vaccine in pigs and cattle.
Yokomizo Y; Watanabe F; Imada Y; Inumaru S; Yanaka T; Tsuji T
Vet Immunol Immunopathol; 2002 Sep; 87(3-4):291-300. PubMed ID: 12072249
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
de Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Vaccine; 1996 Mar; 14(4):260-6. PubMed ID: 8744549
[TBL] [Abstract][Full Text] [Related]
5. Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity.
Kozuka S; Yasuda Y; Isaka M; Masaki N; Taniguchi T; Matano K; Moriyama A; Ohkuma K; Goto N; Udaka S; Tochikubo K
Vaccine; 2000 Mar; 18(17):1730-7. PubMed ID: 10699320
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.
Yuan L; Geyer A; Hodgins DC; Fan Z; Qian Y; Chang KO; Crawford SE; Parreño V; Ward LA; Estes MK; Conner ME; Saif LJ
J Virol; 2000 Oct; 74(19):8843-53. PubMed ID: 10982326
[TBL] [Abstract][Full Text] [Related]
8. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
10. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
[TBL] [Abstract][Full Text] [Related]
11. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
[TBL] [Abstract][Full Text] [Related]
12. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379
[TBL] [Abstract][Full Text] [Related]
14. Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.
Hartman AB; Van De Verg LL; Venkatesan MM
Infect Immun; 1999 Nov; 67(11):5841-7. PubMed ID: 10531238
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin.
Hashigucci K; Ogawa H; Ishidate T; Yamashita R; Kamiya H; Watanabe K; Hattori N; Sato T; Suzuki Y; Nagamine T; Aizawa C; Tamura S; Kurata T; Oya A
Vaccine; 1996 Feb; 14(2):113-9. PubMed ID: 8852406
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
[TBL] [Abstract][Full Text] [Related]
17. Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen.
Kanellos TS; Byarugaba DK; Russell PH; Howard CR; Partidos CD
Immunol Lett; 2000 Nov; 74(3):215-20. PubMed ID: 11064104
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.
Yuan L; Iosef C; Azevedo MS; Kim Y; Qian Y; Geyer A; Nguyen TV; Chang KO; Saif LJ
J Virol; 2001 Oct; 75(19):9229-38. PubMed ID: 11533185
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin.
Byrd W; Cassels FJ
Vaccine; 2003 May; 21(17-18):1884-93. PubMed ID: 12706673
[TBL] [Abstract][Full Text] [Related]
20. Construction of a recombinant-attenuated Salmonella Enteritidis strain secreting Escherichia coli heat-labile enterotoxin B subunit protein and its immunogenicity and protection efficacy against salmonellosis in chickens.
Nandre RM; Lee JH
Vaccine; 2014 Jan; 32(3):425-31. PubMed ID: 24176491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
